Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancerSteven Van Laere, Tim Beissbarth, Ilse Van der Auwera, et al.Seminars in Cancer Biology|October 13, 2019
The potential and controversy of targeting STAT family members in cancerYannick Verhoeven, Sam Tilborghs, Julie Jacobs, et al.International Journal of Molecular Sciences|May 5, 2019
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A ReviewPeter A van Dam, Yannick Verhoeven, Julie Jacobs, et al.Plos One|July 30, 2011
Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinomaXuan Bich Trinh, Wiebren A A Tjalma, Luc Y Dirix, et al.Oncotarget|December 25, 2015
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatmentPeter A van Dam, Pieter-Jan H H van Dam, Christian Rolfo, et al.Cancers|September 28, 2021
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant ChemotherapyChristophe Van Berckelaer, Iris Vermeiren, Leonie Vercauteren, et al.Cancer Treatment Reviews|July 31, 2020
SARS-CoV-2 and cancer: Are they really partners in crime?Peter A van Dam, Manon Huizing, Gino Mestach, et al.Journal for Immunotherapy of Cancer|May 20, 2026
CD155 links tumor immunotype to epithelial-directed precision therapy beyond checkpoint inhibition in cervical cancerYannick Verhoeven, Delphine Quatannens, Sanne van der Heijden, et al.Frontiers in Immunology|June 8, 2026
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trialRegina Esi Mensimah Baiden-Amissah, Sandra Tuyaerts, Daniela Annibali, et al.Gynecologic Oncology|November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trialEmiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.Pageof 4